Objective：To investigate the effect of Dan-gua Fang（丹瓜方） on adenosine 5’-monophosphate（AMP） activated protein kinase（AMPK） α expression in liver and subsequent improvement of glucose and lipid metabolism.M...Objective：To investigate the effect of Dan-gua Fang（丹瓜方） on adenosine 5’-monophosphate（AMP） activated protein kinase（AMPK） α expression in liver and subsequent improvement of glucose and lipid metabolism.Methods：Forty 13-week-old diabetic Goto-Kakizaki（GK） rats were randomly divided into model,Dan-gua Fang,metformin and simvastatin groups（n=10 for each）,and fed high-fat diet ad libitum.Ten Wistar rats were used as normal group and fed normal diet.After 24 weeks,liver expression of AMPK α mRNA was assessed by real-time PCR.AMPK α and phospho-AMPK α protein expression in liver was evaluated by Western blot.Liver histomorphology was carried out after hematoxylin-eosin staining,and blood glucose（BG）,glycosylated hemoglobin A1c（HbA1c）,food intake and body weight recorded.Results：Similar AMPK α mRNA levels were found in the Dan-gua Fang group and normal group,slightly higher than the values obtained for the remaining groups（P〈0.05）.AMPK α protein expression in the Dan-gua Fang group animals was similar to other diabetic rats,whereas phospho-AMPK α（Thr-172） protein levels were markedly higher than in the metformin group and simvastatin group（P〈0.05）,respectively.However,phosphor-AMPKa/AMPK α ratios were similar in all groups.Dan-gua Fang reduced fasting blood glucose with similar strength to metformin,and was superior in reducing cholesterol,triglycerides,high-density lipoprotein cholesterol as well as improving low-density lipoprotein cholesterol in comparison with simvastatin and metformin.Dan-gua Fang decreases plasma alanine aminotransferase（ALT） significantly.Conclusion：Dan-gua Fang,while treating phlegm-stasis,could decrease BG and lipid in type 2 diabetic GK rats fed with high-fat diet,and effectively protect liver histomorphology and function.This may be partly explained by increased AMPK expression in liver.Therefore,Dan-gua Fang might be an ideal drug for comprehensive Intervention for glucose and lipid metabolism disorders in type 2 diabe展开更多
目的探讨长期睡眠剥夺对小鼠肝组织腺苷酸激活蛋白激酶(adenosine 5’-monophosphateactivated protein kinase,AMPK)/沉默信息调节因子1(silent information regulation1,SIRT1)/过氧化物酶体增殖物激活受体γ共激活因子-1α(peroxisom...目的探讨长期睡眠剥夺对小鼠肝组织腺苷酸激活蛋白激酶(adenosine 5’-monophosphateactivated protein kinase,AMPK)/沉默信息调节因子1(silent information regulation1,SIRT1)/过氧化物酶体增殖物激活受体γ共激活因子-1α(peroxisome proliferator-activated receptorγcoactivator 1α,PGC-1α)系统的影响。方法2月龄C57BL/6J小鼠16只随机分为睡眠剥夺组和正常对照组,睡眠剥夺组利用睡眠剥夺仪每天剥夺睡眠20 h,每周剥夺6 d,连续10周。正常对照组在相同实验条件下自由睡眠10周。每周测量一次体重,10周后进行小鼠体成分测定,并采集血液、肝脏和脂肪组织样本,检测血清褪黑素水平、肝组织AMPKα、SIRT1、PGC-1α及胆固醇调节元件结合蛋白1C(sterol regulatory element-binding protein 1C,SREBP-1C)蛋白表达水平,以及脂肪组织中脂肪合成关键酶脂肪酸合成酶(fatty acid synthase,FAS)、乙酰辅酶A羧化酶1(acetyl CoA carbosylase 1,ACC1)表达水平。结果建模结束后,睡眠剥夺组小鼠体重显著高于对照组(F=10.955,P=0.006),且从第6周末开始,睡眠剥夺组小鼠体重明显高于对照组(F=8.535,P=0.012),并且睡眠剥夺组小鼠体脂量[(14.58±1.70)%]高于对照组[(11.24±1.64)%](t=4.007,P=0.001),血清褪黑素浓度[(2.33±0.53)ng/ml]低于对照组[(2.87±0.23)ng/ml](t=2.643,P=0.019),AMPK通路中的AMPKα(t=7.134,P<0.001)、SIRT1(t=7.531,P<0.001)、PGC-1α(t=11.537,P<0.001)表达水平降低,AMPK/SIRT1/PGC-1α通路下调。而SREBP-1C表达水平升高,差异有统计学意义(t=-4.496,P=0.001)。同时睡眠剥夺小鼠脂肪组织中FAS(t=-4.375,P=0.001)、ACC1表达水平均升高(t=-4.072,P=0.001)。结论长期睡眠剥夺可致褪黑素受体介导的AMPK/SIRT1/PGC-1α通路抑制,并且脂肪合成相关基因表达增强,引起能量代谢特别是脂代谢稳态失调和体脂增加。展开更多
AIM To investigate the mechanisms by which Sheng-jiang powder(SJP) ameliorates obesity-induced pancreatic inflammatory injury.METHODS Sprague-Dawley rats were randomized into three groups: normal group(NG), obese grou...AIM To investigate the mechanisms by which Sheng-jiang powder(SJP) ameliorates obesity-induced pancreatic inflammatory injury.METHODS Sprague-Dawley rats were randomized into three groups: normal group(NG), obese group(HLG), or SJP treatment group(HSG). Obesity was induced by feeding a high-fat diet in the HLG and HSG, while the NG received standard chow. Rats were euthanized after 12 wk, and blood and pancreatic tissues were collected for histopathological analyses. Nuclear factor kappa-light-chain-enhancer of activated B cells(NF-κB) and transforming growth factor beta(TGF-β) expression, serum triglyceride and adiponectin levels, and apoptosis in pancreatic acinar cells were assessed. A high-fat AR42 J acinar cell injury model was established using very low-density lipoprotein(VLDL). AR42 J acinar cell culture supernatant, treated with different interventions, was applied to seven groups of pancreatic stellate cells(PSCs). The proliferation of PSCs and the expression of fibronectin and type I collagenase were assessed.RESULTS Compared with the NG, we found higher pathological scores for pancreatic tissues, lower serum adiponectin levels, higher expression levels of NF-κB in pancreatic tissues and TGF-β in pancreatic inflammatory cells, and increased apoptosis among pancreatic acinar cells for the HLG(P < 0.05). Compared with the HLG, we found reduced body weight, Lee's index scores, serum triglyceride levels, and pathological scores for pancreatic tissues; higher serum adiponectin levels; and lower expression levels of NF-κB, in pancreatic tissue and TGF-β in pancreatic inflammatory cells for the HSG(P < 0.05). The in vitro studies showed enhanced PSC activation and increased expression levels of fibronectin and type I collagenase after SJP treatment. An adenosine 5‘-monophosphate-activated protein kinase(AMPK) inhibitor inhibited PSC activation.CONCLUSION SJP may ameliorate obesity-induced pancreatic inflammatory injury in rats by regulating key molecules of the adiponectin-AMPK signalling pathway.展开更多
Objective: To investigate whether ginsenoside-Rb1(Gs-Rb1) improves the CoCl2-induced autophagy of cardiomyocytes via upregulation of adenosine 5’-monophosphate-activated protein kinase(AMPK) pathway. Methods: Ventric...Objective: To investigate whether ginsenoside-Rb1(Gs-Rb1) improves the CoCl2-induced autophagy of cardiomyocytes via upregulation of adenosine 5’-monophosphate-activated protein kinase(AMPK) pathway. Methods: Ventricles from 1-to 3-day-old Wistar rats were sequentially digested, separated and incubated in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum for 3 days followed by synchronization. Neonatal rat cardiomyocytes were randomly divided into 7 groups: control group(normal level oxygen), hypoxia group(500 μmol/L CoCl2), Gs-Rb1 group(200 μmol/L Gs-Rb1 + 500 μmol/L CoCl2), Ara A group(500 μmol/L Ara A + 500 μmol/L CoCl2), Ara A+ Gs-Rb1 group(500 μmol/L Ara A + 200 μmol/L Gs-Rb1 + 500 μmol/L CoCl2), AICAR group [1 mmol/L 5-aminoimidazole-4-carboxamide ribonucleotide(AICAR)+ 500 μmol/L CoCl2], and AICAR+Gs-Rb1 group(1 mmol/L AICAR + 200 μmol/L Gs-Rb1 + 500 μmol/L CoCl2). Cel s were treated for 12 h and cell viability was determined by methylthiazolyldiphenyl-tetrazolium bromide(MTT) assay and cardiac troponin I(cTnI) levels were detected by enzyme-linked immunosorbent assay(ELISA). AMPK activity was assessed by 2’,7’-dichlorofluorescein diacetate(DCFH-DA) ELISA assay. The protein expressions of Atg4 B, Atg5, Atg6, Atg7, microtubule-associated protein 1 A/1 B-light chain 3(LC3), P62, and active-cathepsin B were measured by Western blot. Results: Gs-Rb1 significantly improved the cell viability of hypoxia cardiomyocytes(P<0.01). However, the viability of hypoxia-treated cardiomyocytes was significantly inhibited by Ara A(P<0.01). Gs-Rb1 increased the AMPK activity of hypoxia-treated cardiomyocytes. The AMPK activity of hypoxia-treated cadiomyocytes was inhibited by Ara A(P<0.01) and was not affected by AICAR(P=0.983). Gs-Rb1 up-regulated Atg4B, Atg5, Beclin-1, Atg7, LC3B Ⅱ, the LC3BⅡ/Ⅰ ratio and cathepsin B activity of hypoxia cardiomyocytes(P<0.05), each of these protein levels was significantly enhanced by Ara A(all P<0.01), but was not affected by AICAR(all P展开更多
目的探讨单磷酸腺苷活化蛋白激酶(AMPK)通过调控能量代谢对肿瘤发挥双重作用的机制,为靶向AMPK治疗肿瘤提供理论基础。方法应用PubMed及中国知网数据库检索系统,以“adenosine 5’-monophosphate-activated protein kinase(AMPK)、tumor...目的探讨单磷酸腺苷活化蛋白激酶(AMPK)通过调控能量代谢对肿瘤发挥双重作用的机制,为靶向AMPK治疗肿瘤提供理论基础。方法应用PubMed及中国知网数据库检索系统,以“adenosine 5’-monophosphate-activated protein kinase(AMPK)、tumor、metabolic regulator、Metformin”为英文关键词,以“单磷酸腺苷酸活化蛋白激酶、肿瘤、能量代谢、二甲双胍”为中文关键词,交叉检索2002年1月-2023年4月的相关文献。纳入标准:(1)AMPK的结构及调控能量代谢的作用;(2)AMPK通路在肿瘤中的调控作用;(3)AMPK在肿瘤治疗中的临床应用。排除标准:与肿瘤相关性较小及质量较低的文章。最终纳入文献61篇。结果AMPK在不同肿瘤类型、分期以及治疗方式中,通过调控糖代谢、脂代谢和蛋白质代谢等,发挥抑癌或促癌的双重作用。结论AMPK可以通过调控肿瘤代谢微环境发挥其促癌或抑癌作用,具有潜在的肿瘤临床治疗价值,但其作用于肿瘤的复杂机制仍需进一步探索。展开更多
基金Supported by the National Natural Science Foundation of China(No.81173179)the Natural Science Foundation of Fujian Province(No.2011J01198)+5 种基金the Fujian Medical Innovation Project(No.2009-CX-19)the Research Foundation of Fujian Health Department(No.Zlcnfm02)the Fujian Provincial Department of Education Category A Projects(No.JA09131)the Fujian Health Department of Traditional Chinese Medicine Research(No.WZY0920)the CHEN Ke-ji Integrative Medicine Development Fund(No.CKJ2008047,CKJ2009004)the Integrative Medicine of Fujian Key Laboratory of Age-related Diseases Funded Projects(No.2008J1004-10)
文摘Objective：To investigate the effect of Dan-gua Fang（丹瓜方） on adenosine 5’-monophosphate（AMP） activated protein kinase（AMPK） α expression in liver and subsequent improvement of glucose and lipid metabolism.Methods：Forty 13-week-old diabetic Goto-Kakizaki（GK） rats were randomly divided into model,Dan-gua Fang,metformin and simvastatin groups（n=10 for each）,and fed high-fat diet ad libitum.Ten Wistar rats were used as normal group and fed normal diet.After 24 weeks,liver expression of AMPK α mRNA was assessed by real-time PCR.AMPK α and phospho-AMPK α protein expression in liver was evaluated by Western blot.Liver histomorphology was carried out after hematoxylin-eosin staining,and blood glucose（BG）,glycosylated hemoglobin A1c（HbA1c）,food intake and body weight recorded.Results：Similar AMPK α mRNA levels were found in the Dan-gua Fang group and normal group,slightly higher than the values obtained for the remaining groups（P〈0.05）.AMPK α protein expression in the Dan-gua Fang group animals was similar to other diabetic rats,whereas phospho-AMPK α（Thr-172） protein levels were markedly higher than in the metformin group and simvastatin group（P〈0.05）,respectively.However,phosphor-AMPKa/AMPK α ratios were similar in all groups.Dan-gua Fang reduced fasting blood glucose with similar strength to metformin,and was superior in reducing cholesterol,triglycerides,high-density lipoprotein cholesterol as well as improving low-density lipoprotein cholesterol in comparison with simvastatin and metformin.Dan-gua Fang decreases plasma alanine aminotransferase（ALT） significantly.Conclusion：Dan-gua Fang,while treating phlegm-stasis,could decrease BG and lipid in type 2 diabetic GK rats fed with high-fat diet,and effectively protect liver histomorphology and function.This may be partly explained by increased AMPK expression in liver.Therefore,Dan-gua Fang might be an ideal drug for comprehensive Intervention for glucose and lipid metabolism disorders in type 2 diabe
文摘目的探讨长期睡眠剥夺对小鼠肝组织腺苷酸激活蛋白激酶(adenosine 5’-monophosphateactivated protein kinase,AMPK)/沉默信息调节因子1(silent information regulation1,SIRT1)/过氧化物酶体增殖物激活受体γ共激活因子-1α(peroxisome proliferator-activated receptorγcoactivator 1α,PGC-1α)系统的影响。方法2月龄C57BL/6J小鼠16只随机分为睡眠剥夺组和正常对照组,睡眠剥夺组利用睡眠剥夺仪每天剥夺睡眠20 h,每周剥夺6 d,连续10周。正常对照组在相同实验条件下自由睡眠10周。每周测量一次体重,10周后进行小鼠体成分测定,并采集血液、肝脏和脂肪组织样本,检测血清褪黑素水平、肝组织AMPKα、SIRT1、PGC-1α及胆固醇调节元件结合蛋白1C(sterol regulatory element-binding protein 1C,SREBP-1C)蛋白表达水平,以及脂肪组织中脂肪合成关键酶脂肪酸合成酶(fatty acid synthase,FAS)、乙酰辅酶A羧化酶1(acetyl CoA carbosylase 1,ACC1)表达水平。结果建模结束后,睡眠剥夺组小鼠体重显著高于对照组(F=10.955,P=0.006),且从第6周末开始,睡眠剥夺组小鼠体重明显高于对照组(F=8.535,P=0.012),并且睡眠剥夺组小鼠体脂量[(14.58±1.70)%]高于对照组[(11.24±1.64)%](t=4.007,P=0.001),血清褪黑素浓度[(2.33±0.53)ng/ml]低于对照组[(2.87±0.23)ng/ml](t=2.643,P=0.019),AMPK通路中的AMPKα(t=7.134,P<0.001)、SIRT1(t=7.531,P<0.001)、PGC-1α(t=11.537,P<0.001)表达水平降低,AMPK/SIRT1/PGC-1α通路下调。而SREBP-1C表达水平升高,差异有统计学意义(t=-4.496,P=0.001)。同时睡眠剥夺小鼠脂肪组织中FAS(t=-4.375,P=0.001)、ACC1表达水平均升高(t=-4.072,P=0.001)。结论长期睡眠剥夺可致褪黑素受体介导的AMPK/SIRT1/PGC-1α通路抑制,并且脂肪合成相关基因表达增强,引起能量代谢特别是脂代谢稳态失调和体脂增加。
基金Supported by the National Natural Science Foundation of China,No.81603519 and No.81573857
文摘AIM To investigate the mechanisms by which Sheng-jiang powder(SJP) ameliorates obesity-induced pancreatic inflammatory injury.METHODS Sprague-Dawley rats were randomized into three groups: normal group(NG), obese group(HLG), or SJP treatment group(HSG). Obesity was induced by feeding a high-fat diet in the HLG and HSG, while the NG received standard chow. Rats were euthanized after 12 wk, and blood and pancreatic tissues were collected for histopathological analyses. Nuclear factor kappa-light-chain-enhancer of activated B cells(NF-κB) and transforming growth factor beta(TGF-β) expression, serum triglyceride and adiponectin levels, and apoptosis in pancreatic acinar cells were assessed. A high-fat AR42 J acinar cell injury model was established using very low-density lipoprotein(VLDL). AR42 J acinar cell culture supernatant, treated with different interventions, was applied to seven groups of pancreatic stellate cells(PSCs). The proliferation of PSCs and the expression of fibronectin and type I collagenase were assessed.RESULTS Compared with the NG, we found higher pathological scores for pancreatic tissues, lower serum adiponectin levels, higher expression levels of NF-κB in pancreatic tissues and TGF-β in pancreatic inflammatory cells, and increased apoptosis among pancreatic acinar cells for the HLG(P < 0.05). Compared with the HLG, we found reduced body weight, Lee's index scores, serum triglyceride levels, and pathological scores for pancreatic tissues; higher serum adiponectin levels; and lower expression levels of NF-κB, in pancreatic tissue and TGF-β in pancreatic inflammatory cells for the HSG(P < 0.05). The in vitro studies showed enhanced PSC activation and increased expression levels of fibronectin and type I collagenase after SJP treatment. An adenosine 5‘-monophosphate-activated protein kinase(AMPK) inhibitor inhibited PSC activation.CONCLUSION SJP may ameliorate obesity-induced pancreatic inflammatory injury in rats by regulating key molecules of the adiponectin-AMPK signalling pathway.
基金Supported by Shenyang Innovation Foundation of Science and Technology–the Application Projects of Basic Research(No.F15-199-1-06)Liaoning Province Science and Technique Foundation of China(No.2015020282)
文摘Objective: To investigate whether ginsenoside-Rb1(Gs-Rb1) improves the CoCl2-induced autophagy of cardiomyocytes via upregulation of adenosine 5’-monophosphate-activated protein kinase(AMPK) pathway. Methods: Ventricles from 1-to 3-day-old Wistar rats were sequentially digested, separated and incubated in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum for 3 days followed by synchronization. Neonatal rat cardiomyocytes were randomly divided into 7 groups: control group(normal level oxygen), hypoxia group(500 μmol/L CoCl2), Gs-Rb1 group(200 μmol/L Gs-Rb1 + 500 μmol/L CoCl2), Ara A group(500 μmol/L Ara A + 500 μmol/L CoCl2), Ara A+ Gs-Rb1 group(500 μmol/L Ara A + 200 μmol/L Gs-Rb1 + 500 μmol/L CoCl2), AICAR group [1 mmol/L 5-aminoimidazole-4-carboxamide ribonucleotide(AICAR)+ 500 μmol/L CoCl2], and AICAR+Gs-Rb1 group(1 mmol/L AICAR + 200 μmol/L Gs-Rb1 + 500 μmol/L CoCl2). Cel s were treated for 12 h and cell viability was determined by methylthiazolyldiphenyl-tetrazolium bromide(MTT) assay and cardiac troponin I(cTnI) levels were detected by enzyme-linked immunosorbent assay(ELISA). AMPK activity was assessed by 2’,7’-dichlorofluorescein diacetate(DCFH-DA) ELISA assay. The protein expressions of Atg4 B, Atg5, Atg6, Atg7, microtubule-associated protein 1 A/1 B-light chain 3(LC3), P62, and active-cathepsin B were measured by Western blot. Results: Gs-Rb1 significantly improved the cell viability of hypoxia cardiomyocytes(P<0.01). However, the viability of hypoxia-treated cardiomyocytes was significantly inhibited by Ara A(P<0.01). Gs-Rb1 increased the AMPK activity of hypoxia-treated cardiomyocytes. The AMPK activity of hypoxia-treated cadiomyocytes was inhibited by Ara A(P<0.01) and was not affected by AICAR(P=0.983). Gs-Rb1 up-regulated Atg4B, Atg5, Beclin-1, Atg7, LC3B Ⅱ, the LC3BⅡ/Ⅰ ratio and cathepsin B activity of hypoxia cardiomyocytes(P<0.05), each of these protein levels was significantly enhanced by Ara A(all P<0.01), but was not affected by AICAR(all P
文摘目的探讨单磷酸腺苷活化蛋白激酶(AMPK)通过调控能量代谢对肿瘤发挥双重作用的机制,为靶向AMPK治疗肿瘤提供理论基础。方法应用PubMed及中国知网数据库检索系统,以“adenosine 5’-monophosphate-activated protein kinase(AMPK)、tumor、metabolic regulator、Metformin”为英文关键词,以“单磷酸腺苷酸活化蛋白激酶、肿瘤、能量代谢、二甲双胍”为中文关键词,交叉检索2002年1月-2023年4月的相关文献。纳入标准:(1)AMPK的结构及调控能量代谢的作用;(2)AMPK通路在肿瘤中的调控作用;(3)AMPK在肿瘤治疗中的临床应用。排除标准:与肿瘤相关性较小及质量较低的文章。最终纳入文献61篇。结果AMPK在不同肿瘤类型、分期以及治疗方式中,通过调控糖代谢、脂代谢和蛋白质代谢等,发挥抑癌或促癌的双重作用。结论AMPK可以通过调控肿瘤代谢微环境发挥其促癌或抑癌作用,具有潜在的肿瘤临床治疗价值,但其作用于肿瘤的复杂机制仍需进一步探索。
